practical implications of the maia study for mm
Published 5 years ago • 102 plays • Length 7:10Download video MP4
Download video MP3
Similar videos
-
7:15
maia trial: transplant-ineligible patients with mm
-
2:37
updated analysis of the maia trial: long-term safety and efficacy data
-
15:30
overall survival results in transplant-ineligible newly diagnosed mm pts: phase 3 maia study
-
1:47
practical management of iv daratumumab in mm
-
10:04
nccn guidelines for newly diagnosed mm
-
2:53
daratumumab in the treatment landscape for mm
-
4:03
maia and alcyone: follow-up of daratumumab in multiple myeloma
-
41:15
quadruplets in newly diagnosed transplant-ineligible myeloma
-
17:33
the importance of timely and accurate diagnosis in multiple myeloma - dr joseph mikhael - full video
-
13:11
coomassie purity staining of recombinant antibodies - addgene protocol
-
14:55
progress report iii - tímea mátyási-dombi
-
0:52
dr. pecora on updated maia data in multiple myeloma
-
2:21
the role of daratumumab in the treatment of myeloma and insights into the maia trial
-
1:13
updated maia trial data show improved survival for multiple myeloma
-
1:43
practical considerations for monoclonal antibodies in multiple myeloma
-
1:08
long term follow-up results from the phase iii maia trial in myeloma
-
1:09
daratumumab enhancement for mm: the clinical impact
-
0:51
lessons from the aspire trial: three drug regimens as the new soc for relapsed mm
-
6:20
5-year data supports efficacy and safety of daratumumab as add-on therapy for multiple myeloma
-
7:49
clinical significance of mrd testing in mm
-
0:59
ithaca trial results: combination of isatuximab, lenalidomide & dexamethasone for high-risk smm
-
1:54
forte update: carfilzomib-lenalidomide induction therapy for mm